Carolyn Johnson

Carolyn Johnson is a Scientist II in Translational Science at Sage Therapeutics, focusing on preclinical functional biomarker strategies to enhance lead optimization and support first-in-human studies. Prior experience includes a tenure as a Postdoctoral Researcher at Harvard University, where Carolyn characterized phenotypes of a mouse model of chronic early life stress and identified therapeutic targets related to GABAergic interneuron development. Earlier, Carolyn held postdoctoral positions at the University of California, Berkeley, and conducted graduate studies at the University of California, San Francisco, combining advanced imaging techniques with behavioral studies. Carolyn's academic background includes a Ph.D. in Neuroscience from the University of California, San Francisco, a Master's in Pharmacology from the University of Gothenburg, and a Bachelor of Arts in Neuroscience from Bowdoin College.